Dyslipidemia management among patients with high and very high cardiovascular risk in Indonesia: a multi-center registry
Abstract
Background
Indonesia, the world's largest archipelago, faces significant challenges in equitable healthcare delivery due to its geographical and infrastructural disparities. Atherosclerotic Cardiovascular Disease (ASCVD) remains the leading cause of mortality, with over 659,000 deaths recorded in 2019. Effective dyslipidemia management is crucial for preventing adverse ASCVD events. Unfortunately, the lack of implementation of an updated national lipid management registry might hinder optimal strategy for the adverse events. This study evaluated dyslipidemia cholesterol management practices among high- and very high-risk patients across the country.
Methods
The study recruited 322 patients from eight centers across six provinces in Indonesia between May 2022 and March 2023. Patients were stratified based on the ASCVD risk and followed over three visits. Baseline clinical characteristics, lipid profiles, and treatment regimens were analyzed. Descriptive statistics summarized continuous and categorical variables, and low-density lipoprotein cholesterol (LDL-C) achievement was assessed.
Results
Of the 322 patients, 98.8% were very high-risk, with only 4.9% achieving <55 mg/dL and 21.2% achieving <70 mg/dL. Moderate-intensity statins were the most prescribed (51.2%), followed by high-intensity (36.6%). LDL-C reduction was most pronounced in private insurance patients, achieving a mean LDL-C of 69.8 mg/dL at the third visit compared to 98.9 mg/dL in National Health Insurance (Jaminan Kesehatan Nasional/JKN) participants. Missed visit rates increased over time, with 57.5% of patients missing the third visit, predominantly among JKN participants and low-income groups.
Conclusion
Majority of the population failed to achieve the recommended target of LDL-C levels. Dyslipidemia management in Indonesia remains suboptimal, with disparities driven by socioeconomic factors. Improved policies addressing medication availability, national lipid registry establishment, and equitable healthcare access are essential to enhance lipid management and reduce the burden of ASCVD in Indonesia.
Downloads
References
1. Badan Pusat Statistik. Mid Year Population – Indonesia. 2025. Available at: https://www.bps.go.id/en/statistics-table/2/MTk3NSMy/mid-year-population--thousand-people-.html. Accessed 26 February 2025.
2. Badan Pusat Statistik. Jumlah Rumah Sakit Umum, Rumah Sakit Khusus, dan Puskesmas. 2015. Available at: https://www.bps.go.id/id/statistics-table/2/MjMyIzI=/jumlah-rumah-sakit-umum-rumah-sakit-khusus-dan-puskesmas.html. Accessed 21 December 2024.
3. National Institute of Health Research and Development of The Indonesia Ministry of Health. The 2018 Indonesia Basic Health Survey (Riskesdas): National Report. Jakarta; 2019
4. Indonesia Ministry of Health (Kementerian Kesehatan RI). National Guidelines for Noncommunicable Diseases Prevention and Control. Jakarta, Indonesia: Directorate General of Disease Prevention and Control; 2023. https://p2p.kemkes.go.id/wp-content/uploads/2023/12/FINAL_231123_Layout-PTM_Bahasa-Inggris.pdf. Accessed 21 December 2024.
5. GBD 2019 Universal Health Coverage Collaborators. Deaths due to cardiovascular diseases in Southeast Asia, 2019. Lancet Glob Health. 2019;8:e321–e431.
6. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 guideline on the management of blood cholesterol. Journal of the American College of Cardiology. 2018;73(24).
7. Reiner Z, Catapano AL, G. De Backer, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal. 2011;32(14):1769–818.
8. Erwinanto et al. PANDUAN TATA LAKSANA DISLIPIDEMIA. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia; 2022.
9. Juzar DA, Muzakkir AF, Ilhami YR, Taufiq N, Kusmana D, Astiawati T, et al. Management of Acute Coronary Syndrome in Indonesia: Insight from One ACS Multicenter Registry. Indones J Cardiol. 2022;43:45–55.
10. Valee A. Association between socio-economic status - and estimated atherosclerotic cardiovascular risk: results from a middle-aged population-based study. Public Health 2023 Aug: 221: 1-9. Doi: 10.1016/puhe.2023.05.014. Epub 2023 Jun 16.
11. Task Force Members, Montalescot G, Sechtem U, Achenbah S, Andreotti F, Arden C. et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34(7): 2949-3003.
PDF downloads: 798
Copyright (c) 2025 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
